Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism
about
sameAs
Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retentionDNA methylation maintains allele-specific KIR gene expression in human natural killer cellsInteraction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cellsT-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effectMutational and Structural Analysis of KIR3DL1 Reveals a Lineage-Defining Allotypic Dimorphism That Impacts Both HLA and Peptide SensitivityFunctional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinomaOpen conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1Enrichment of variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU patients: an exploratory studyMeiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypesAsian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression.Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402.Development of a novel multiplex PCR assay to detect functional subtypes of KIR3DL1 allelesEffects of activating NK cell receptor expression and NK cell reconstitution on the outcomes of unrelated donor hematopoietic cell transplantation for hematologic malignancies.KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motifInnate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.Primate-specific regulation of natural killer cells.Copy number variation of KIR genes influences HIV-1 control.Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations.Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes.KIR3DL3 allelic diversity: six new alleles exhibit both conservative and non-conservative substitutions.KIR gene content in amerindians indicates influence of demographic factors.Identification of cell surface molecules characterizing human cutaneous T-cell lymphomas.The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif.Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1Variable NK cell receptors exemplified by human KIR3DL1/S1Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.MHC class I molecules and KIRs in human history, health and survival.Innate immune control of HIV.Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.KIR-HLA intercourse in HIV diseaseThe characteristics of allelic polymorphism in killer-immunoglobulin-like receptor framework genes in African Americans.Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the moleculeThe D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer.Putting the natural killer cell in its place.Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses.
P2860
Q24598715-241DD74C-10ED-4BDC-B8C6-2F3EA8641624Q24673791-AB0A1932-237C-4C2D-926C-C554EB66AC91Q26314406-DEE6B8C7-6B66-455B-A53B-A4C9C9723D87Q26826830-2985A65C-713F-4937-BCB6-19CF274B49D6Q27681870-6F26B9A8-26B5-4045-91F6-F4FE53C2821BQ28210382-422989B9-5C4B-4763-8A31-DD0AF5CEC17AQ28277389-CBB60A08-4877-4016-B2CA-C80D2EE2E581Q28740790-9F56422F-7DCE-4EF7-9CB2-CB4ABE7444E1Q28754594-93DEBE61-5000-4029-9FAB-0F8698720BA3Q33356381-94F62064-EDC2-4853-A9AD-A94AC1DD9CC2Q33384422-241E28B3-9EC4-4FBF-8804-1AA08E3FCA37Q33672480-7C659ED2-DB3F-4419-8AF1-3BF34E69567DQ33682888-04FEAD87-90FF-4D2D-8255-274AD696B24EQ33740971-832ADD0D-E14E-498D-B9A7-EE2CC9A3B6A0Q33777096-6BA88B88-5EF8-41D0-A63D-1B2AC1E22980Q33851496-C01F0F15-FAB0-43C0-86ED-BDA3BF43FAC0Q34056087-7EF0D79E-0E41-49EB-9556-77F7B90319FFQ34064807-B4146663-B639-4D79-B2F2-EEEE839DB6E0Q34090869-E0CBCF90-1383-4CB2-8671-2D2C0017F065Q34124327-C7655A51-195C-462A-B343-7CDFB5897EF7Q34362162-1CF32C18-2041-4B10-A91A-1EF0C18F292EQ34516982-B77CAE2C-161F-4C9D-873D-2FA463DA94ECQ34602592-63303589-3E11-49CB-98D8-1C17F2732E14Q34769861-19AC52D4-AAAA-4702-B17D-0720FA63C436Q35030951-3DD6984E-8C5D-48D5-BB64-46D76ABEB2EFQ35076703-E1CA9BF0-CC21-418B-8B54-8058AC170D90Q35077002-10493280-9C27-4226-9309-226CFDE13F4DQ35175810-E94D90BB-5D87-4465-AB55-3F586C6049CAQ35570313-39340F4A-12F3-47ED-B4E4-C5252B07F958Q35847425-1E61978E-DE7F-4680-8B28-BF1C7A66CA55Q35864564-4796B053-5D6A-42D1-AC97-11BEEF00A707Q36047157-B8D5A1D6-4CB4-479C-8F36-C6F6CD39CFFFQ36065864-FA66DBA0-1B05-4F74-9E64-E605C70FCF47Q36228467-8EE0BAD6-FDC6-4AF6-A7B6-5EA3DDF6ECE9Q36296307-691B300B-37B1-4F61-BA0C-6C8ED9D9B9D1Q36334403-64835027-177D-43AE-8C13-68FF16A48697Q36366692-B14B9A79-03B1-4618-8510-B763E204BE34Q36371178-64AA45CB-B41E-4814-8903-2A89E09BC27AQ36372539-5821D19F-1A68-48CF-B65B-0C5FC400EF5DQ36407362-C0552B2F-AF30-460A-B827-E132E70F4FFD
P2860
Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Different NK cell surface phen ...... e to KIR3DL1 gene polymorphism
@ast
Different NK cell surface phen ...... e to KIR3DL1 gene polymorphism
@en
Different NK cell surface phen ...... e to KIR3DL1 gene polymorphism
@nl
type
label
Different NK cell surface phen ...... e to KIR3DL1 gene polymorphism
@ast
Different NK cell surface phen ...... e to KIR3DL1 gene polymorphism
@en
Different NK cell surface phen ...... e to KIR3DL1 gene polymorphism
@nl
prefLabel
Different NK cell surface phen ...... e to KIR3DL1 gene polymorphism
@ast
Different NK cell surface phen ...... e to KIR3DL1 gene polymorphism
@en
Different NK cell surface phen ...... e to KIR3DL1 gene polymorphism
@nl
P2093
P3181
P1476
Different NK cell surface phen ...... e to KIR3DL1 gene polymorphism
@en
P2093
H G Shilling
L A Guethlein
R Rajalingam
P304
P3181
P356
10.4049/JIMMUNOL.166.5.2992
P407
P577
2001-03-01T00:00:00Z